• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correlation of PSMA-Targeted F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.

作者信息

Tosoian Jeffrey J, Gorin Michael A, Rowe Steven P, Andreas Darian, Szabo Zsolt, Pienta Kenneth J, Pomper Martin G, Lotan Tamara L, Ross Ashley E

机构信息

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Clin Genitourin Cancer. 2017 Feb;15(1):e65-e68. doi: 10.1016/j.clgc.2016.09.002. Epub 2016 Sep 19.

DOI:10.1016/j.clgc.2016.09.002
PMID:27751686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5572129/
Abstract
摘要

相似文献

1
Correlation of PSMA-Targeted F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.PSMA靶向的F-DCFPyL PET/CT检查结果与转移性神经内分泌前列腺癌患者免疫组织化学及基因组数据的相关性
Clin Genitourin Cancer. 2017 Feb;15(1):e65-e68. doi: 10.1016/j.clgc.2016.09.002. Epub 2016 Sep 19.
2
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL in peripheral ganglia.外周神经节中前列腺特异性膜抗原（PSMA）靶向的F-DCFPyL摄取模式。
Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.
3
Prospective Comparison of PET Imaging with PSMA-Targeted F-DCFPyL Versus NaF for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.PSMA 靶向 F-DCFPyL PET 显像与 NaF 用于检测转移性前列腺癌骨转移病灶的前瞻性比较。
J Nucl Med. 2020 Feb;61(2):183-188. doi: 10.2967/jnumed.119.227793. Epub 2019 Aug 26.
4
PSMA-Targeted F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy.PSMA靶向的F-DCFPyL PET/CT对透明细胞肾细胞癌的成像：快速尸检结果
Eur Urol. 2017 Jan;71(1):145-146. doi: 10.1016/j.eururo.2016.06.019. Epub 2016 Jun 28.
5
Comparison between F-DCFPyL PET and MRI for the detection of transition zone prostate cancer.F-DCFPyL正电子发射断层扫描（PET）与磁共振成像（MRI）在检测前列腺移行区癌方面的比较。
Prostate. 2021 Dec;81(16):1329-1336. doi: 10.1002/pros.24230. Epub 2021 Sep 13.
6
Semiquantitative Parameters in PSMA-Targeted PET Imaging with F-DCFPyL: Variability in Normal-Organ Uptake.使用F-DCFPyL进行PSMA靶向PET成像的半定量参数：正常器官摄取的变异性
J Nucl Med. 2017 Jun;58(6):942-946. doi: 10.2967/jnumed.116.179739. Epub 2016 Dec 8.
7
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.用于前列腺癌特异性膜抗原（PSMA）靶向PET成像的[(18)F]DCFPyL的初步评估
Mol Imaging Biol. 2015 Aug;17(4):565-74. doi: 10.1007/s11307-015-0850-8.
8
Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.基于有效的前列腺特异性膜抗原的18F-DCFPyL引导下对一名在11C-胆碱PET/CT上被认为转移可能性更大的患者的单个阳性部位进行冷冻消融。
Clin Nucl Med. 2017 Dec;42(12):e516-e518. doi: 10.1097/RLU.0000000000001846.
9
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT.多参数 MRI 和 PSMA 靶向 18F-DCFPyL PET/CT 揭示的不寻常阴茎前列腺癌病例。
Clin Nucl Med. 2017 Oct;42(10):e441-e443. doi: 10.1097/RLU.0000000000001785.
10
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on F-DCFPyL PET/CT Imaging.PSMA-RADS 1.0 标准化报告系统在 F-DCFPyL PET/CT 成像中的观察者间一致性。
J Nucl Med. 2018 Dec;59(12):1857-1864. doi: 10.2967/jnumed.118.217588. Epub 2018 Sep 6.

引用本文的文献

1
High-Affinity Probes for Androgen Receptor Imaging: From Cells and Modeling to Whole-Body Fluorescent Applications.用于雄激素受体成像的高亲和力探针：从细胞与模型到全身荧光应用
J Med Chem. 2025 Aug 14;68(15):15812-15827. doi: 10.1021/acs.jmedchem.5c00836. Epub 2025 Jul 25.
2
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer.血浆表观基因组分析揭示前列腺癌中出现的治疗性鳞状化生。
NPJ Precis Oncol. 2025 Jul 9;9(1):233. doi: 10.1038/s41698-025-01031-3.
3
The additive value of Ga-RM26 PET/CT to Ga-PSMA-617 PET/CT in assessing Post-treatment outcomes of ARSIs in mCRPC patients.镓标记的RM26正电子发射断层扫描/计算机断层扫描（Ga-RM26 PET/CT）相对于镓标记的PSMA-617正电子发射断层扫描/计算机断层扫描（Ga-PSMA-617 PET/CT）在评估转移性去势抵抗性前列腺癌（mCRPC）患者雄激素受体信号抑制剂（ARSIs）治疗后结局中的附加价值。
Eur J Nucl Med Mol Imaging. 2025 Jun 16. doi: 10.1007/s00259-025-07407-8.
4
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.使用靶向CD46的225Ac疗法有效治疗播散性前列腺癌。
Clin Cancer Res. 2025 Jul 15;31(14):2963-2977. doi: 10.1158/1078-0432.CCR-24-2850.
5
A Case of Rapidly Progressive De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer.一例快速进展的原发性转移性小细胞神经内分泌前列腺癌病例。
Case Rep Oncol Med. 2024 Sep 17;2024:7998149. doi: 10.1155/2024/7998149. eCollection 2024.
6
PSMA PET/CT imaging and its application to prostate cancer treatment.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像及其在前列腺癌治疗中的应用。
Jpn J Radiol. 2025 Jan;43(1):1-12. doi: 10.1007/s11604-024-01646-9. Epub 2024 Sep 3.
7
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.胃泌素释放肽受体（GRPR）作为前列腺癌的新型生物标志物和治疗靶点。
Ann Med. 2024 Dec;56(1):2320301. doi: 10.1080/07853890.2024.2320301. Epub 2024 Mar 5.
8
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.癌症细胞谱系可塑性的转录和表观遗传景观。
Cancer Discov. 2023 Aug 4;13(8):1771-1788. doi: 10.1158/2159-8290.CD-23-0225.
9
Radiotheranostics in advanced prostate cancer: Current and future directions.晚期前列腺癌中的放射治疗诊断学：现状与未来方向
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):11-21. doi: 10.1038/s41391-023-00670-6. Epub 2023 Apr 14.
10
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.用靶向 CD46 的 225Ac 放射性核素 α 粒子免疫治疗治疗前列腺癌。
Clin Cancer Res. 2023 May 15;29(10):1916-1928. doi: 10.1158/1078-0432.CCR-22-3291.

本文引用的文献

1
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.前列腺癌中前列腺特异性膜抗原的正电子发射断层显像：当前技术水平与未来挑战
Prostate Cancer Prostatic Dis. 2016 Sep;19(3):223-30. doi: 10.1038/pcan.2016.13. Epub 2016 May 3.
2
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.基于前列腺特异性膜抗原（PSMA）的[18F]DCFPyL正电子发射断层扫描/计算机断层扫描（PET/CT）在检测转移性前列腺癌患者的病灶方面优于传统成像。
Mol Imaging Biol. 2016 Jun;18(3):411-9. doi: 10.1007/s11307-016-0957-6.
3
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?基于¹⁸F-DCFPyL PET/CT的前列腺癌骨转移灶PSMA检测：(⁹⁹m)Tc-MDP骨扫描和¹⁸F-Na PET/CT的敏感替代方法？
Clin Genitourin Cancer. 2016 Feb;14(1):e115-8. doi: 10.1016/j.clgc.2015.09.011. Epub 2015 Sep 30.
4
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.细胞周期蛋白D1缺失可将前列腺小细胞癌与大多数前列腺腺癌区分开来。
Clin Cancer Res. 2015 Dec 15;21(24):5619-29. doi: 10.1158/1078-0432.CCR-15-0744. Epub 2015 Aug 5.
5
Prostate-specific membrane antigen as a target for cancer imaging and therapy.前列腺特异性膜抗原作为癌症成像和治疗的靶点。
Q J Nucl Med Mol Imaging. 2015 Sep;59(3):241-68. Epub 2015 Jul 24.
6
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.复发前列腺癌患者中[(18)F]DCFPyL与[(68)Ga]Ga-PSMA-HBED-CC用于PSMA-PET成像的比较
Mol Imaging Biol. 2015 Aug;17(4):575-84. doi: 10.1007/s11307-015-0866-0.
7
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.用于前列腺癌特异性膜抗原（PSMA）靶向PET成像的[(18)F]DCFPyL的初步评估
Mol Imaging Biol. 2015 Aug;17(4):565-74. doi: 10.1007/s11307-015-0850-8.
8
Cancer statistics, 2015.癌症统计数据，2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
9
Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.转移性低分化前列腺癌伴神经内分泌分化：68Ga-PSMA PET/CT 阴性。
Clin Nucl Med. 2015 Feb;40(2):e163-6. doi: 10.1097/RLU.0000000000000594.
10
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.视网膜母细胞瘤缺失是前列腺小细胞神经内分泌癌的特征。
Clin Cancer Res. 2014 Feb 15;20(4):890-903. doi: 10.1158/1078-0432.CCR-13-1982. Epub 2013 Dec 9.